3 TeenCOVE study of its COVID-19 vaccine (mRNA-1273) met its primary immunogenicity endpoint in adolescents. The study showed no cases of COVID-19 infection in individuals administered with two doses of the Moderna COVID-19 vaccine using the primary definition.
https://www.tipranks.com/news/moderna-submits-authorization-application-for-use-of-covid-19-vaccine-in-swiss-adolescents
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Jun 2021 to Jul 2021 Click Here for more Moderna Charts.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Jul 2020 to Jul 2021 Click Here for more Moderna Charts.